�� Tempus AI ($TEM) — one of the hottest (and most shorted) names in precision medicine.

Uses AI + genomic + clinical + imaging data to push personalized healthcare.

IPO’d last year, now valued at ~$15B.

Shorts are piling in — ~25% of the float is shorted, making it one of the most bet-against biotech/AI plays right now.

Analysts see targets around $73–75 (range $60–98), the stock trades in the mid-$90s today.

⚖️ The Setup:

Bulls: “AI + precision medicine = huge TAM, game-changer for oncology & beyond.”

Bears: “High burn, IP lawsuits, and expectations already sky-high.”

�� With short interest this high, TEM is a battleground stock. One breakthrough could squeeze shorts — one stumble could crush longs.



@Market coverage